Investment Pitches

Pitch Summary:
Broad pressure on software stocks enabled us to initiate a position in Constellation Software. It is a permanent capital vehicle acquiring vertical market software businesses and holding them indefinitely. Founder Mark Leonard enforces strict capital allocation discipline with IRR hurdles above 20%. These businesses generate high recurring free cash flow, which is reinvested to compound value. The stock now offers an attractive free cash flow yield of about 5%, near an all-time low valuation.

BSD Analysis:
Constellation is one of the cleanest capital allocation machines ever built, quietly acquiring niche software businesses that never show up in hype cycles. Its focus on vertical market software creates extreme stickiness because customers run mission-critical operations with zero appetite for change. Growth looks incremental by design, but returns compound because acquisition discipline never slips. Investors struggle to model it because value is created deal by deal, not quarter by quarter. Pricing power exists because software costs are trivial relative to the disruption of switching. Decentralization prevents bureaucracy from killing incentives. This is private equity logic executed permanently inside a public company.

Pitch Summary:
We took advantage of a consolidation in Broadcom’s stock price to initiate a position. Broadcom’s semiconductor design unit has a dominant position in custom chips (ASICs) for cloud hyperscalers and companies building LLMs. GPUs remain indispensable for training, but inference economics favor custom chips. Broadcom designed Google’s TPUs, giving it a proven track record. Its networking business is benefiting from data center build-out, and VMware benefits from IT hardware fragmentation.

BSD Analysis:
Broadcom’s moat is engineered scarcity—high-performance chips and mission-critical software sold with ruthless pricing discipline. Customer concentration is high, but dependence runs both ways once Broadcom’s components are designed in. The software portfolio adds stability and cash flow that smooths semiconductor cycles. Growth is selective by design; Broadcom would rather walk away than discount. Capital allocation is aggressive and unapologetically shareholder-first. Integration risk exists, but execution history earns credibility. The bull case is sustained AI and networking demand plus software cash flows. The bear case is customer pushback against pricing power. Broadcom wins by saying “no” more than competitors say “yes.”

Pitch Summary:
ServiceNow was the second largest detractor this year, with its stock down 27.7%. It suffered from fears that AI will disrupt enterprise software. We think ServiceNow suffers from none of that. On the contrary, it is well positioned to become the connective tissue between enterprises’ AI applications. Fragmentation of IT assets increases the value added by the NOW platform. Recent acquisitions added pressure, but their strategic rationale makes sense and their size is modest relative to the business.

BSD Analysis:
ServiceNow’s moat is workflow entrenchment at the center of enterprise IT and operations. Once critical processes run on Now, ripping it out becomes organizational trauma. Growth is driven by expansion within existing customers rather than greenfield wins. Pricing power is strong because value is tied to efficiency, not seat counts. The risk is saturation at large enterprises, forcing heavier reliance on upsell. Competition exists, but displacement is rare once embedded. Execution must stay tight as the platform broadens beyond ITSM. The bull case is becoming the operating system for enterprise workflows. ServiceNow compounds as infrastructure, not just software.

Pitch Summary:
Diageo detracted most from performance after its stock slumped 29.4% over the year. Demand for spirits remains subdued, with excess inventories normalizing only slowly, while trade war and tariff uncertainties weighed further. The stock has now reached its lowest point since 2015 and the lowest valuation in its history. We think that has gone too far. The cycle will normalize at some point, providing support for demand and the resumption of long-term premiumization trends. The appointment of Dave Lewis as CEO and the reappointment of Nik Jhangiani as CFO should reinforce focus on profitability and capital discipline.

BSD Analysis:
Diageo’s moat is brand power layered on global distribution—consumers don’t easily abandon iconic spirits. Pricing power is real but works best gradually; push too hard and elasticity shows up. Premiumization flatters margins until wallets tighten and mix shifts reveal reality. Emerging markets offer growth but inject FX and political volatility. Innovation matters less than brand stewardship and route-to-market discipline. Inventory and distributor relationships quietly drive short-term results. The bull case is steady global spirits demand with disciplined price realization. The bear case is demand softness exposing price-led growth. Diageo compounds when it respects pacing.

Pitch Summary:
Microsoft, our largest holding, was the third largest contributor to 2025 performance, with the stock up 15.6%. Driven by its cloud business, the company continues to grow its revenue and income at a fast clip. The stickiness and breadth of its software user base, its integrated cloud infrastructure (Azure) and early collaboration with OpenAI position it well as one of the main AI solution providers for enterprises. The US$60bn war chest on its balance sheet is a further strength at a time when doubts are emerging around some tech companies’ ability to finance their capex plans.

BSD Analysis:
Microsoft’s moat is institutional embedment at enterprise scale—once inside workflows, it almost never leaves. Azure doesn’t need to dominate cloud; it just needs to remain unavoidable for existing customers. AI expands the opportunity set while locking Microsoft into massive, ongoing capex. Bundling strengthens pricing power but steadily increases regulatory scrutiny. Execution has been consistently elite, which raises the bar for any slowdown. Margins hold because switching costs are organizational, not technical. The bull case is AI monetization layered across a captive enterprise base. Microsoft is dominance monetized patiently, not disruption monetized loudly.

Pitch Summary:
Applied Material contributed most to portfolio performance both on an annual basis and in Q4. The stock was up respectively 59.6% and 25.8%, adding 2.1% and 1.1% to performance. Both Applied Materials and ASML design tools necessary in the manufacture of semiconductor chips. Their fundamental prospects are bright given how much silicon is required for the deployment of AI.

BSD Analysis:
Applied Materials sits at the center of the semiconductor arms race, supplying tools that get more valuable as chips get harder to make. AI, advanced packaging, and leading-edge nodes all increase process complexity — and Applied gets paid per step. The company’s breadth across deposition, etch, and materials engineering creates cross-selling leverage competitors struggle to match. Cyclicality is unavoidable, but the baseline demand curve keeps rising. Services revenue from the installed base smooths downturns. Customer concentration exists, but switching costs are brutal once fabs are configured. Capital intensity is high, but returns justify it. This is not gadget exposure. It’s semiconductor infrastructure with physics on its side.

Pitch Summary:
This is a U.S. activist campaign by Impactive Capital. WEX owns three high-quality, market-leading businesses with dominant share and recurring revenue, yet trades at ~9x forward earnings due to poor capital allocation, bloated costs, weak governance, and empire-building acquisitions. Impactive believes spinning off the higher-multiple Benefits segment and closing a large margin gap with peers could drive 50%+ upside. A full proxy contest is underway following minimal board concessions by management.

BSD Analysis:
WEX is payments infrastructure disguised as a niche fintech, monetizing closed-loop ecosystems where generic cards don’t work. Fleet, travel, and corporate payments are compliance-heavy and operationally embedded, which creates real switching costs. Growth optics fluctuate with fuel prices and travel cycles, but take rates and retention remain strong. Investors fixate on near-term volume noise and miss the durability of vertical-specific rails. Pricing power exists because WEX solves reconciliation headaches, not convenience purchases. Capital-light economics support strong free cash flow. This is boring payments that stick because they remove friction where it actually hurts.

Pitch Summary:
This is a U.S. activist campaign led by JANA Partners and Sachem Head. Following the Cedar Fair merger, Six Flags suffered severe share price declines due to weather-driven earnings misses, leverage, and poor operational execution. JANA, alongside multiple other activists, is pushing for operational fixes, technology integration, improved capital discipline, real estate monetization, and potentially a sale of assets or the entire company. The appointment of a new CEO and the involvement of high-profile board candidates are central to the turnaround thesis.

BSD Analysis:
Six Flags is experiential entertainment with brutal operating leverage in both directions. Attendance swings drive earnings faster than pricing tweaks. Investors fixate on weather, debt, and consumer cycles, which are real but not the whole story. Park assets are irreplaceable in their local markets, creating regional monopolies. Cost control and capital discipline matter more than new ride announcements. When attendance normalizes, cash flow snaps back quickly. This is asset-heavy entertainment where execution defines outcomes more than demand trends.

Pitch Summary:
This is a U.S. activist campaign by Irenic Capital. Integer is the only publicly traded pure-play medical device CDMO, serving OEMs like Medtronic and Boston Scientific in highly regulated, sticky end markets. A temporary demand air pocket caused shares to fall over 40%, despite management guiding to growth normalization in 2027. Irenic has called for board refreshment and exploration of a potential sale, arguing that Integer is structurally better suited for private ownership. Comparable transactions suggest a valuation north of $120 per share versus roughly 10x EBITDA currently.

BSD Analysis:
Integer is medtech manufacturing infrastructure embedded deep in customers’ supply chains. It doesn’t invent devices; it makes sure they actually get built to regulatory standards. Switching suppliers is painful once validation and FDA processes are complete. Investors treat Integer like a generic contract manufacturer and miss the moat created by compliance and quality. Demand tracks procedure volumes and innovation cycles, not consumer sentiment. Margin expansion comes from mix and operational execution. This is picks-and-shovels healthcare with long-cycle stickiness.

Pitch Summary:
This is a Japanese activist campaign by Elliott Investment Management. Kansai Electric Power is Japan’s most profitable electric utility, with nearly half of output derived from nuclear power and EBITDA dominated by its core regulated business. Despite this, the company trades at a deep discount following a poorly timed ¥500 billion equity issuance. Elliott sees four levers for value creation: materially higher dividends, improved capital efficiency through buybacks, monetization of over ¥2 trillion in non-core real estate and businesses, and better pricing power in liberalized commercial markets. Additional upside exists from AI-driven data center demand, where KEPCO’s low-cost nuclear power provides a competitive advantage.

BSD Analysis:
Kansai Electric is regulated utility infrastructure in a country that values reliability over disruption. Nuclear restarts materially change the earnings profile by lowering fuel costs and stabilizing margins. Demand is steady, not exciting, which is exactly why the model works. Investors focus on regulatory and political overhangs and miss improving cash flow visibility. Japan’s energy security priorities favor incumbents with proven operating capability. Capital intensity is high, but recovery mechanisms are clearer than in the past. This is utility math slowly normalizing after years of shock. Stability is the edge.

Pitch Summary:
This is a Japanese activist campaign by Third Point. Ebara Corporation was founded over 100 years ago and established its roots as an industrial manufacturer of pumps, compressors, chillers, turbines, and related equipment. These core manufactured products (“Fluid Machinery”) are relatively mature and low-growth. However, over the last several decades, Ebara has quietly become a semiconductor capital equipment powerhouse through its Precision Equipment business, which now contributes approximately one-third of revenue and over half of operating income. Despite forming a CMP duopoly with Applied Materials and benefiting disproportionately from AI-driven advanced packaging demand, Ebara continues to trade closer to its legacy industrial valuation. Third Point is engaging management on margin expansion, enhanced capital returns, and governance improvements, including board refreshment and better capital allocation, which could materially close the valuation gap.

BSD Analysis:
Ebara is a classic sum-of-the-parts mispricing where a high-growth semiconductor equipment business is buried inside a legacy industrial multiple. CMP intensity is structurally rising due to advanced packaging and AI chips, directly benefiting Ebara’s metal CMP dominance. Margins lag peers materially, creating clear operational upside. Capital returns are conservative relative to cash generation. Activism provides a credible catalyst for rerating toward semi-cap peers.

Pitch Summary:
We sold our position in Integer Holdings Corp. during the quarter. ITGR lowered its revenue and earnings guidance for the fourth quarter and 2026 during its third quarter earnings conference call due to unexpected notification by customers that sales of three new products will decline in 2026, given that market adoption of these products has been slower than forecasted. Given ITGR’s limited visibility regarding these products, we chose to sell the position.

BSD Analysis:
Integer is a contract manufacturer embedded in complex medical device supply chains. Switching suppliers is risky and expensive for OEMs. Demand follows procedure volumes over time. Margins improve with mix shift toward higher-value components. Capacity investments create operating leverage. Investors treat it like generic manufacturing. In reality, qualification barriers matter. As medtech volumes normalize, earnings accelerate. This is hidden medtech leverage.

Pitch Summary:
We sold our position in HealthStream Inc. during the quarter. While we believe the company has developed the healthcare industry’s largest ecosystem of platform-delivered workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care, HSTM has faced challenges with commercialization of the offering. We may revisit the stock if we see evidence of commercial traction.

BSD Analysis:
HealthStream sells workforce training and credentialing software to hospitals. Compliance and certification needs are non-discretionary. Revenue is sticky and recurring. Growth is modest but predictable. Hospitals don’t switch platforms lightly. Investors ignore HealthStream because it’s slow. But slow plus essential equals durable. Margin expansion comes from scale, not sales heroics. This is healthcare admin infrastructure. Boring is the moat.

Pitch Summary:
PayPal Holdings detracted from performance during the quarter. The Company reported +8% volume growth and +12% adjusted earnings per share growth. However, management cited slowing transaction volumes late in the quarter tied to a weaker macro environment. PayPal also announced increased investment in agentic commerce initiatives, raising expense levels. We trimmed the position as slower volume growth and higher costs are likely to pressure profit growth.

BSD Analysis:
PayPal is fighting to prove it’s still essential in digital payments rather than just “the old button.” The network is massive, and trust matters in payments more than fintech Twitter admits. Growth slowed, but cash generation remains strong, giving management room to refocus. The upside hinges on improving branded checkout relevance and expanding merchant services that deepen relationships. Competition is fierce, yet scale and distribution still provide advantages. Investors price PayPal like a melting ice cube, which feels too pessimistic if execution tightens. If engagement stabilizes and take-rate holds, the rerating can be meaningful. This is a turnaround of perception as much as fundamentals.

Pitch Summary:
Aoyama Zaisan Networks (-16%) was the most significant detractor as it revised FY2025 revenue guidance downwards. AZN revised its revenue guidance downwards by -11% for FY2025 due to revenue from transactions at Advantage Club, AZN’s real estate co-ownership platform, being pushed to later periods.

BSD Analysis:
Aoyama Zaisan Networks plays in the advisory and asset-structuring ecosystem serving Japan’s wealth, succession, and corporate needs—areas that quietly expand as demographics shift. Japan’s aging population and inheritance dynamics create structural demand for planning and advisory services. The model can be relationship-driven and slow to scale, but that also supports client stickiness. Revenue can be lumpy depending on deal timing, yet long-term demand is durable. Investors often ignore these firms because they don’t look like high-growth tech, but the economics can be excellent when confidence is high. If Japan’s corporate governance reforms keep moving capital around, advisory firms like this benefit. The key is disciplined execution and reputation, because one misstep can poison the well. This is demographic-finance exposure with underappreciated durability.

Pitch Summary:
Where our conviction has changed, we have taken action, including the sale of Tecan and AutoStore, which no longer met our standards for long-term growth durability.

BSD Analysis:
Tecan is a premium life sciences automation player enabling labs to scale workflows with less labor and higher reproducibility. As biology becomes more data-driven, automation becomes less optional and more core infrastructure. Funding cycles can pause orders, but they rarely kill demand—labs delay and then catch up. Tecan’s positioning in liquid handling and instrument platforms creates sticky relationships and recurring consumables and service revenue. Margins reflect specialization, not commodity manufacturing. Investors often overreact to short-term destocking and underweight the long-term shift to automated labs. If biopharma and diagnostics capex normalizes, Tecan tends to bounce hard because of operating leverage. This is a high-quality picks-and-shovels name with periodic sentiment-driven discounts.

Pitch Summary:
Where our conviction has changed, we have taken action, including the sale of Tecan and AutoStore, which no longer met our standards for long-term growth durability.

BSD Analysis:
AutoStore is a warehouse automation pure-play selling a modular robotics system that turns space constraints into productivity gains. The thesis is straightforward: e-commerce and labor scarcity force automation, and AutoStore sits in the sweet spot of ROI-driven capex. Demand is cyclical with customer budgets, but the long-term penetration of automated fulfillment remains early. The ecosystem model with integrators expands distribution without AutoStore carrying all the implementation burden. Competition is rising, yet AutoStore’s installed base and performance track record create real inertia. Investors swing between hype and despair, but the core math of automation doesn’t change. If capex cycles thaw, bookings can rebound sharply, and operating leverage is meaningful. This is industrial tech volatility with a secular tailwind underneath.

Pitch Summary:
Universal Display has the right products for the right customers, but we are waiting for demand for its organic LED materials to pick up. Their strong market position for these products is assured by what we believe to be outstanding intellectual property.

BSD Analysis:
Universal Display is effectively a royalty company on OLED adoption, with economics most hardware suppliers would envy. Its phosphorescent materials are embedded in OLED displays across smartphones, TVs, and wearables. Revenue can be lumpy, but margins are extraordinary due to IP dominance. OLED penetration continues to expand as performance improves and costs fall. The long-term driver is display area growth, not unit growth. Investors worry about customer concentration, yet no credible substitute exists today. R&D spending reinforces the moat rather than threatens margins. Universal Display doesn’t need explosive growth to win. Time and adoption do the work.

Pitch Summary:
Advanced Energy is helping its customers meet an insatiable demand for reliable computing capacity with its power management products for the data center. Other segments are also generally performing well.

BSD Analysis:
Advanced Energy supplies mission-critical power and control systems that sit deep inside semiconductor manufacturing and industrial processes. Its products are not optional upgrades; they are essential to yield and uptime. Semiconductor capex cycles create volatility, but Advanced Energy benefits disproportionately when spending resumes. The company’s exposure to advanced nodes and display manufacturing adds diversification. Margins fluctuate with volume, yet the IP content supports long-term pricing power. Investors often trade the cycle and miss the structural relevance. As chip complexity rises, power precision matters more. Advanced Energy is a picks-and-shovels name in advanced manufacturing. Cycles hurt, but relevance compounds.

Pitch Summary:
Illumina, with almost 70% market share in gene sequencing, has weathered a storm of life science funding cuts and competitive entries. While the coast is not completely clear, they remain well positioned to benefit from any acceleration in both clinical and research spending in the life sciences.

BSD Analysis:
Illumina remains the backbone of genomic sequencing, even as regulatory missteps and execution errors have punished the stock. The core sequencing franchise is still unrivaled in scale, accuracy, and installed base, which creates massive switching costs. Near-term growth has been weighed down by funding slowdowns in biotech and academic research. However, demand for genomics is structural, driven by oncology, diagnostics, and population-scale sequencing programs. Cost cuts and refocus on the core business are restoring margin credibility. The failed Grail acquisition damaged trust, but it did not erode Illumina’s technological moat. Investors treat Illumina like a broken growth story rather than an infrastructure asset in biology. As funding cycles normalize, volumes tend to rebound sharply. This is a wounded monopoly, not a displaced one.